90 related articles for article (PubMed ID: 6789937)
1. Long survival in acute myelogenous leukaemia.
Freeman CB; Harris R; Taylor GM
Br Med J (Clin Res Ed); 1981 Jul; 283(6284):139. PubMed ID: 6789937
[No Abstract] [Full Text] [Related]
2. Long survival in acute myelogenous leukaemia.
Lucie NP; Dagg JH; Prentice AG; Smith AG
Br Med J (Clin Res Ed); 1981 May; 282(6274):1472. PubMed ID: 6784869
[No Abstract] [Full Text] [Related]
3. Long survival in acute myelogenous leukaemia: an international collaborative study.
Whittaker JA; Reizenstein P; Callender ST; Cornwell GG; Delamore IW; Gale RP; Gobbi M; Jacobs P; Lantz B; Maiolo AT; Rees JK; Van Slyck EJ; Van HV
Br Med J (Clin Res Ed); 1981 Feb; 282(6265):692-5. PubMed ID: 6781618
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in acute leukemias. Possible applications in children.
Mahoney DH; Starling KA
Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for acute myelogenous leukaemia.
Powles R
Br J Cancer Suppl; 1973 Aug; 1():262-5. PubMed ID: 4531352
[No Abstract] [Full Text] [Related]
6. The effect of immunotherapy on survival of patients with acute myelogenous leukaemia after relapse.
Powles R; Toy JL
Haematologia (Budap); 1976; 10(1):5-9. PubMed ID: 1070466
[TBL] [Abstract][Full Text] [Related]
7. [Survival in adults with acute myelogenous leukemia].
Tangen JM; Fløisand Y; Foss-Abrahamsen J; Haukås E; Naess IA; Skjelbakken T
Tidsskr Nor Laegeforen; 2008 May; 128(10):1164-7. PubMed ID: 18480864
[TBL] [Abstract][Full Text] [Related]
8. Inability to demonstrate lytic antibodies to autologous leukaemia cells in the sera from remission patients with acute myelogenous leukaemia treated with active specific immunotherapy.
Chapuis BJ; Powles R; Alexander P
Clin Exp Immunol; 1978 May; 32(2):253-8. PubMed ID: 276431
[TBL] [Abstract][Full Text] [Related]
9. Survival from adult leukaemia in England and Wales up to 2001.
Milligan DW
Br J Cancer; 2008 Sep; 99 Suppl 1(Suppl 1):S119-20. PubMed ID: 18813244
[No Abstract] [Full Text] [Related]
10. Letter: Survival in acute myeloid leukaemia.
Lancet; 1975 Nov; 2(7944):1091. PubMed ID: 53575
[No Abstract] [Full Text] [Related]
11. [Acute myelogenous leukaemia of adults: diagnosis, prognosis and treatment (author's transl)].
Abbrederis K; Michlmayr G; Schmalzl F; Huber H; Braunsteiner H
Dtsch Med Wochenschr; 1973 Sep; 98(38):1743-7. PubMed ID: 4517776
[No Abstract] [Full Text] [Related]
12. Management of adult acute myelogenous leukaemia.
Crowther D; Powles RL; Bateman CJ; Beard ME; Gauci CL; Wrigley PF; Malpas JS; Fairley GH; Scott RB
Br Med J; 1973 Jan; 1(5846):131-7. PubMed ID: 4513355
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival in acute myelogenous leukemia complicated by chronic active hepatitis.
Rotoli B; Formisano S; Martinelli V; Nigro M
N Engl J Med; 1982 Dec; 307(27):1712-3. PubMed ID: 6958976
[No Abstract] [Full Text] [Related]
14. Immunotherapy of acute myelogenous leukemia in man.
Powles R
Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
[No Abstract] [Full Text] [Related]
15. [Prolonged survival in adults with acute myeloid leukemia treated with BCG immunotherapy].
Vu Van H; Guyotat D; Fière D; Adeleine P; Gentilhomme O; Treille D; Imbert C; Coiffier B; Bryon PA; Viala JJ
Nouv Presse Med; 1982 Dec; 11(49):3637-9. PubMed ID: 6962421
[TBL] [Abstract][Full Text] [Related]
16. Formula predicting survival in patients with acute myelogenous leukemia.
Chung SJ
Int J Biomed Comput; 1991 Dec; 29(3-4):283-93. PubMed ID: 1778643
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of acute myeloid leukaemia (AML) in UK: past, present and future.
Rees JK
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():110-3. PubMed ID: 2653483
[No Abstract] [Full Text] [Related]
18. [5-year-survival in a case of acute myelogenous leukemia in an adult].
Suzuki C; Shibata A; Onodera S; Miura A; Sakamoto S
Naika; 1971 Feb; 27(2):382-6. PubMed ID: 5278694
[No Abstract] [Full Text] [Related]
19. Re-emerging Philadelphia chromosome-positive acute leukaemia more than 20 years after allogeneic haematopoietic stem cell transplantation.
Kodama Y; Okamura J; Fukano R; Nakashima K; Ito N; Nishimura M; Abe Y; Suzuki T; Inagaki J
Br J Haematol; 2013 Apr; 161(2):286-9. PubMed ID: 23294201
[No Abstract] [Full Text] [Related]
20. Active specific immunotherapy for acute myelogenous leukaemia.
Powles R
Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
[No Abstract] [Full Text] [Related]
[Next] [New Search]
